|BIBCL -- India Stock|| |
INR 11.26 0.37 3.18%
The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners
to view more equity screening tools
Earnings Per Share Analysis
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share
| = |
| = |
About Earnings Per Share
Earnings per Share is one of the most important measures of the current share price of a firm, and is used by investors to determine the company overall profitability; especially when it is compared to the EPS of similar companies.
According to company disclosure Bharat Immunologicals Biologicals Corp Ltd has Earnings Per Share of -0.85 times. This is 213.33% lower than that of the Healthcare sector, and 2933.33% lower than that of Biotechnology
industry, The Earnings Per Share for all stocks is 136.96% higher than the company.
Bharat Immunologicals Fundamental Drivers Relationships
Bharat Immunologicals Biologicals Corp Ltd is number one stock in return on equity category among related companies. It is number one stock in gross profit category among related companies .